NDC 0010-3827 - PromAce
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0010-3827
- Package NDCs from labels
- 0010-3827-01
- Manufacturer
- Boehringer Ingelheim Animal Health USA Inc.
- Effective date
- 2025-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PromAce ® Injectable (acepromazine maleate injection) | Boehringer Ingelheim Animal Health USA Inc. | 2025-03-27 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0010-3827-01 | PromAce | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION | 50 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ACEPROMAZINE MALEATE | ACTIVE INGREDIENT | 37862HP2OM | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| ACEPROMAZINE | ACTIVE MOIETY | 54EJ303F0R | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PROMACE (ACEPROMAZINE MALEATE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Nauzene | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | a60660b2-c5db-45a0-885f-de93e655380d | 2025-04-29 | Warnings | B22547B95K |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | XF417D3PSL |
| Bio Co Enzyme Phase | ACONITICUM ACIDUM, CIS-, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ADRENALINUM, , ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, ASCORBICUM ACIDUM, BARIUM OXALSUCCINICUM, BETA VULGARIS, CERIUM OXALICUM, CITRICUM ACIDUM, CYSTEINUM, FUMARICUM ACIDUM, HEPAR SULPHURIS CALCAREUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM PHOSPHORICUM, NADIDUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PANTOTHENIC ACID, PROTEUS (MORGANI), PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, | Deseret Biologicals, Inc. | 6edee6eb-0ec9-4d2a-9dc9-dc2a6503a6db | 2025-04-08 | Warnings | XF417D3PSL |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| AeroWash Eyewash | EYEWASH SOLUTION | Aero Healthcare US LLC | a477de08-4301-0ee5-e053-2995a90af79d | 2025-02-26 | Warnings | 059QF0KO0R |
| Advanced Eye Relief Eye Wash | WATER SOLUTION | Bausch & Lomb Incorporated | 9caccce1-4530-441d-bf76-244edeb9dedc | 2025-02-17 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products, Inc. | 2d90c8e8-f479-3535-e063-6394a90af122 | 2025-02-07 | Warnings | 059QF0KO0R |
| Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | c9d0e9c8-379f-4895-b272-329efab575c4 | 2025-01-24 | Warnings, Adverse reactions | B22547B95K |
| Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 0775912f-f14a-4967-ac00-c8c1b36040bf | 2025-01-23 | Warnings, Adverse reactions | B22547B95K |
| Medics Choice Soothing Eye Wash | PURIFIED WATER | KC Pharmaceuticals, Inc. | 10e49808-161e-f4ec-e063-6294a90a1775 | 2025-01-19 | Warnings | 059QF0KO0R |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | AvPAK | fe070e2e-3e72-fb84-e053-6294a90afd88 | 2025-01-09 | Adverse reactions | XF417D3PSL |
| STERILE WATER | STERILE WATER | HF Acquisition Co. LLC, DBA HealthFirst | 74ed2a6f-824c-a1ff-e053-2a91aa0a57c0 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.